about
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.Neuromyelitis optica with hypothalamic involvement.Prolactin and neuroimmunomodulation: in vitro and in vivo observations.Experimental allergic encephalomyelitis in pituitary-grafted Lewis rats.Nocturnal plasma melatonin and alpha-melanocyte stimulating hormone levels during exacerbation of multiple sclerosis.Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple SclerosisIncreased plasma/serum levels of prolactin in multiple sclerosis: a meta-analysis.Longer T(2) relaxation time is a marker of hypothalamic gliosis in mice with diet-induced obesity.Gender and sex hormones in multiple sclerosis pathology and therapy.Serum Prolactin Levels in Multiple Sclerosis, Neuromyelitis Optica, and Clinically Isolated Syndrome Patients.Female reproductive issues in multiple sclerosis.Prolactin in multiple sclerosis.Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?The Level of Testosterone, Vitamin D, and Irregular Menstruation More Important than Omega-3 in Non-Symptomatic Women Will Define the Fate of Multiple Scleroses in Future.Dopamine, T cells and multiple sclerosis (MS).Prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas.Prolactin stimulation in multiple sclerosis--an indicator of disease subtypes and activity?Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica.Relationship of nocturnal melatonin levels to duration and course of multiple sclerosis.Effects of multiple sclerosis and medications on menopausal age.Alterations in neuronal gene expression profiles in response to experimental demyelination and axonal transection.Female infertility and multiple sclerosis: is this an issue?
P2860
Q30816299-1125AC63-3045-40F4-8A3E-9F9AE55BED3CQ31007929-AD700E81-0502-41AF-AF08-79B764E83E99Q33692654-DE0EC5FA-F601-4A82-9607-78947D111829Q35023074-60793051-33FA-457E-9961-5D8A50142A21Q35223138-F3E9EC19-56C6-4AE3-9C39-C4B76AB4E3D4Q35876713-CE24B417-D2FE-4CDE-895B-38E4D2E1A72EQ36259406-A3052A24-AA7E-45BC-ADC1-06BA0A9FC258Q36923627-997B1C13-7FA6-4710-96E7-7F22ABD8E614Q37209917-5A3CFC41-B279-4817-86B3-DDEEAB310C24Q37703766-E71EAD76-C67C-45F1-9FBA-F290D29DB55AQ38021743-8DC34CE8-292C-401D-ACC2-C39FD7FC1F18Q38039054-19D6688D-E246-4CF1-9FEA-58BAA81728C8Q38052870-40B98EFF-91E4-4E34-AFFF-624BA01F7F9BQ38783057-508FDC4E-8AE4-4693-9075-95DE68759EECQ39173551-502D5DFF-B0EC-4D4D-964E-AB53AAB8BA97Q40174707-B5E8AE1B-CE47-444A-A458-332590D4F3AFQ44056508-72F1A796-E810-4B69-B757-72E880D6A0A1Q46211869-08EAE797-9F5D-47B1-8139-FD85138B6756Q48147091-E090D765-21ED-4A1F-8263-654A38802FFFQ48247654-6BDDA88B-D9BA-4B56-A439-89D70DFDA486Q48340172-AC5ABF37-180C-4193-AA1B-75A9B85D04D3Q51064079-768C1CB4-445A-4D1F-9BAF-5B67DF60DD42
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Hyperprolactinemia in multiple sclerosis.
@en
Hyperprolactinemia in multiple sclerosis.
@nl
type
label
Hyperprolactinemia in multiple sclerosis.
@en
Hyperprolactinemia in multiple sclerosis.
@nl
prefLabel
Hyperprolactinemia in multiple sclerosis.
@en
Hyperprolactinemia in multiple sclerosis.
@nl
P2093
P1476
Hyperprolactinemia in multiple sclerosis.
@en
P2093
P356
10.1016/0022-510X(91)90094-N
P577
1991-03-01T00:00:00Z